Strata Critical Medical, Inc. (NASDAQ: SRTA) is a Healthcare company (Medical - Care Facilities) with a market capitalization of $468M. The Maz Rating grades it against the other companies in its sector.
Strata Critical Medical, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $5.24, Strata Critical Medical, Inc. trades at 1.7x sales and 1.7x book value. Over the last twelve months it generated about $278M of revenue and a net loss of $26M. It runs a gross margin of 20.6%, an operating margin of -6.6% and a net margin of -8.8%. It shows return on equity of -8.9%, return on invested capital of -6.5% and a free cash flow yield of 0.1%. On the balance sheet: a debt-to-equity ratio of 0.01 and a current ratio of 2.77. Over the past 52 weeks the share price ranged from $3.95 to $6.50, with a beta of 2.56.
Strata Critical Medical, Inc. does not currently pay a dividend.
6 Wall Street analyst ratings cover the stock: 6 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.